Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...
Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug ...
Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...
Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
ZME Science on MSN9h
A Simple Blood Test Called PAC-MANN Could Detect Pancreatic Cancer Early and Save Thousands of LivesA new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...
A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential ...
ThePrint on MSN1d
A personalised vaccine for pancreatic cancer brings ‘hope where none existed before’Researchers associated with the New York-based Memorial Sloan Kettering Cancer Center have obtained positive results in the ...
According to the American Cancer Society, people diagnosed with pancreatic cancer have a 13% chance of living five years ...
A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the ...
Half of all pancreatic-cancer patients live less than a year after diagnosis. But researchers say there is potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback